• Exchange: Natl India
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Generic Pharmaceuticals

Morepen Laboratories Ltd

+ Add to Watchlist


4.85 INR 0.05 1.02%

As of 07:06:13 ET on 07/23/2014.

Snapshot for Morepen Laboratories Ltd (MORE)

Open: 4.85 Day's Range: 4.80 - 4.95 Volume: 181,288
Previous Close: 4.90 52wk Range: 2.05 - 6.15 1-Yr Rtn: +86.54%

Stock Chart for MORE

No chart data available.
  • MORE:IN 4.85
  • 1D
  • 1M
  • 1Y
Interactive MORE Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for MORE

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SENSEX -
Earnings Per Share (ttm) -0.1262
Est. EPS -
Est. PEG Ratio -
Market Cap (M INR) 1,471.98
Shares Outstanding (M) 303.50
30 Day Average Volume 418,150
Price/Book (mrq) 0.7342
Price/Sale (ttm) 0.6193
Dividend Indicated Gross Yield -%
Cash Dividend (INR) 0.6000
Dividend Ex-Date 09/18/2002
5 Year Dividend Growth -
Next Earnings Announcement 05/22/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for MORE

  • Revenue
  • Net Income (M/INR)
  • Profit Margin (%)

Company Profile & Key Executives for MORE

Morepen Laboratories Limited develops, manufactures and markets generic drugs and pharmaceutical formulations for domestic and international customers. The Company's products are available in a variety of formulations, including tablets, capsules, injections, ointments, syrups, and powders. Morepen's products include Loratadine, Fluvastatin, Montelukast, and Fexofenadine.

Sushil SuriChairman/Managing DirectorAjay Kumar SharmaCFO/Compliance Officer
Arun Kumar SinhaExecutive DirectorSanjay SharmaExecutive Director
More Company Profile & Key Executives for MORE

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil